Phlexglobal Launches Research Nurse Bank
Phlexglobal
, has broadened its personnel provision with the launch of a new Research Nurse Bank.
Following client requests, the Research Nurse Bank has been opened to supply skilled nursing staff on a temporary basis to both commercial and NHS clients. With experience of providing clinical research support at the client’s site, the nurses will be available for all phases of clinical trials.
The new initiative is an extension to Phlexglobal’s Task Force, which supplies experienced clinical research personnel, including CRAs, CTAs, QA personnel, research governance assistants/managers and document managers for interim and short term projects.
To compliment the new Task Force extension, Phlexglobal’s training division has added a new research nurse training program to its recently launched training curriculum, which specialzses in tuition for nurses wishing to move into the clinical research field (Essential Skills for Clinical Researchers: Research Nurse), as well as ongoing development for experienced nurses (Advanced Skills for Research Nurses).
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
